menu search

Phio pharmaceuticals presents new data for targeting of brd4 with its intasyl™ compound ph-894

preclinical data shows melanoma cells treated with PH-894 makes them more recognizable to immune cel...

October 11, 2023, 11:30 am

Relmada therapeutics to present new preclinical data on its psilocybin program at aasld the liver meeting® 2023

Low-dose psilocybin generated s tatistically significant reduc tions in liver fat content, plasma glucose levels and body weight gain in a mice model ...

October 11, 2023, 8:31 am

Cybrexa therapeutics to debut preclinical data demonstrating cbx-15 is safe and highly efficacious in 13762 triple negative breast cancer model at 35th aacr-nci-eortc symposium

preclinical Data Demonstrate CBX-15’s Anti-Tumor Efficacy in Animal Models and Ability to Enhance Imm...

October 10, 2023, 12:05 pm

Kineta to present preclinical data on vista blocking kva12123 at immuno us 2023

SEATTLE, Oct. 09, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu...

October 9, 2023, 4:10 pm

Kineta to present preclinical data on vista blocking kva12123 at immuno us 2023

SEATTLE, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immun...

October 9, 2023, 12:10 pm

Agenus: getting the tough decisions right with catalysts ahead

AGEN has chosen to focus its efforts on botensilimab and balstilimab, postponing its other clinical and precli...

October 6, 2023, 6:38 pm

Athira pharma presents preclinical data further supporting the therapeutic potential of ath-1105 in amyotrophic lateral sclerosis (als)

New results support the neuroprotective effects of ATH-1105 in preclinical models of ALS, as indicated ...

October 5, 2023, 8:30 pm

Neurona therapeutics announces publication in cell stem cell reporting the development of investigational novel regenerative cell therapy strategy for drug-resistant focal epilepsy

Publication demonstrates robust and reproducible generation of pure pallial, medial ganglionic eminence (MGE)-type GABAergic inhibitory interneuron ce...

October 5, 2023, 3:00 pm

Immuneering to present preclinical data on imm-1-104 and imm-6-415 at aacr-nci-eortc international conference on molecular targets and cancer therapeutics

CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company developing medicines for...

October 4, 2023, 4:05 pm

Omega therapeutics to present new preclinical data on otx-2101 at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics

CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pion...

October 4, 2023, 4:00 pm

Black diamond therapeutics to present preclinical and clinical data at the aacr-nci-eortc international conference on molecular targets and cancer therapeutics

CAMBRIDGE, Mass. and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage precision oncology ...

October 4, 2023, 12:14 pm

Kura oncology announces three presentations at aacr-nci-eortc international conference on molecular targets and cancer therapeutics

– Presentations to highlight preclinical data supporting combination of KO-2806 with targeted therapi...

October 4, 2023, 11:30 am

$vktx: consolidation in viking therapeutics provides an opportunity

Viking Therapeutics Inc. is an innovative biotechnology company developing novel therapeutics for metabolic and endocrine diseases. Metabolic and rare...

October 2, 2023, 6:17 pm

Candel therapeutics announces three abstracts accepted for poster presentations at sitc 2023 annual meeting

One clinical poster detailing initial overall survival and immunological biomarker data from the ongoing, randomized, open-label phase 2 clinical tria...

September 27, 2023, 1:40 pm

Allogene therapeutics announces three poster presentations from its next generation allocar t™ platform at the society for immunotherapy of cancer (sitc) annual meeting

Spotlight on Novel, Targeted Technologies to Enhance Engraftment, Expansion and Persistence of AlloCAR T™ Cells Demonstration of Dagger™ Technolog...

September 27, 2023, 1:09 pm

Crispr therapeutics to present at the society for immunotherapy of cancer (sitc) 38th annual meeting

ZUG, Switzerland and BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating tr...

September 27, 2023, 9:01 am

Transcode therapeutic stock whipsaws lower after cut price placing

TransCode Therapeutics (NASDAQ:RNAZ) stock has seen a wild 24 hours of trading as the Boston headquartered nano-cap drug discovery firm rocketed Monda...

September 26, 2023, 6:47 am

Kineta to present new preclinical data on lead anti-cd27 agonist antibody at aacr special conference on tumor immunology and immunotherapy

SEATTLE, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu...

September 25, 2023, 9:30 am

Novo nordisk partners with valo health on ai drug discovery

Novo Nordisk NVO, +0.01% on Monday announced a partnership with Valo Health Inc., a technology company specializing in AI-powered drug discovery and d...

September 25, 2023, 8:28 am


Search within

Pages Search Results: